The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Sector
Contract Manufacturing
WuXi AppTec reports record revenue in 2025 despite US-China geopolitical tensions
The Chinese CRDMO’s revenue generated from the U.S. market increased $34.3% year-over-year, while Europe and China declined last year compared to 2024.
March 24, 2026
API
API Innovation Center works to reshore generic drug production
March 23, 2026
Contract Manufacturing
Lifecore expects 2026 revenue to decline by 12%-15% due to customer-driven factors
March 17, 2026
Contract Manufacturing
Lonza divests capsules and health ingredients business for $2.2B in upfront cash
March 9, 2026
Contract Manufacturing
Stevanato Group’s GLP-1 revenue grows more than 50% in 2025
March 5, 2026
Contract Manufacturing
WuXi Biologics accelerates development, manufacturing with robust model, platforms
Feb. 27, 2026
Contract Manufacturing
Agilent’s Biovectra drives GLP-1 growth with ‘healthy’ contribution from the CDMO
Feb. 26, 2026
Contract Manufacturing
Charles River inks agreement to divest CDMO, cell solutions businesses to GI Partners
Feb. 25, 2026
Contract Manufacturing
IDT Biologika looks to double its sales by 2028 in post-acquisition growth phase
Feb. 24, 2026
Looking for Something?
Load More Content
